Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 514.00K | 485.00K | 412.00K | 388.00K | 299.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 514.00K | 485.00K | 412.00K | 388.00K | 299.00K |
| Cost of Revenue | 261.00K | 264.00K | 230.00K | 242.00K | 25.00K |
| Gross Profit | 253.00K | 221.00K | 182.00K | 146.00K | 274.00K |
| SG&A Expenses | 1.70M | 1.81M | 2.13M | 2.22M | 1.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49M | 2.50M | 2.81M | 2.84M | 1.93M |
| Operating Income | -1.97M | -2.01M | -2.40M | -2.45M | -1.63M |
| Income Before Tax | -1.98M | -2.00M | -2.48M | -2.64M | -1.83M |
| Income Tax Expenses | -- | -- | 1.00K | -- | 4.00K |
| Earnings from Continuing Operations | -1.98M | -2.00M | -2.48M | -2.64M | -1.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.98M | -2.00M | -2.48M | -2.64M | -1.83M |
| EBIT | -1.97M | -2.01M | -2.40M | -2.45M | -1.63M |
| EBITDA | -1.93M | -1.97M | -2.37M | -2.41M | -1.59M |
| EPS Basic | -0.10 | -0.13 | -0.20 | -0.20 | -0.14 |
| Normalized Basic EPS | -0.06 | -0.08 | -0.11 | -0.11 | -0.09 |
| EPS Diluted | -0.10 | -0.13 | -0.20 | -0.20 | -0.14 |
| Normalized Diluted EPS | -0.06 | -0.08 | -0.11 | -0.11 | -0.09 |
| Average Basic Shares Outstanding | 20.58M | 16.23M | 13.61M | 13.50M | 12.67M |
| Average Diluted Shares Outstanding | 20.58M | 16.23M | 13.61M | 13.50M | 12.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |